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FGM
INTRODUCTION
AkiDwA, the African and Migrant Women’s Network in
Ireland, developed this resource as part of a project
funded by the Office of the Minister for Integration,
examining the health-care needs of women who have
undergone female genital mutilation (FGM) in their
countries of origin and who now reside in Ireland. As
the project developed in 2008, it became apparent that
there were few resources for health-care professionals
working in Ireland encountering these women, who
may have very specific and urgent health-care needs.
03
As a result of successful collaboration between the Royal College of Surgeons in Ireland’s MSc Women's
Health course director and students, and the coordinator of the Migrant Women's Health Services Project
in AkiDwA, key information on FGM and related health-care needs was researched and developed. Irish
FGM-prevalence statistics were collated during 2008 and are also contained in this resource.
It is envisaged that this resource will be useful to a range of health-care professionals in a broad
spectrum of possible settings. The removable image sheet is designed to be used with a patient or
client to illustrate FGM typologies and FGM prevalence across Africa.
This resource would not have been completed without the active participation and assistance of the
AkiDwA FGM Health Forum members (listed below), the board and staff of AkiDwA, the significant
contribution from the RCSI, and the courageous women who have endured FGM and are seeking
supports and services in Ireland.
Meghan Doherty, Policy Officer, Irish Family Planning Association
Sarah Duku, Resource and Information Coordinator, Cáirde
Margaret Dunlea, Lecturer in Midwifery, School of Nursing and Midwifery, Trinity College Dublin
Alessandra Fantini, Policy Officer, Women's Health Council
Breda Gahan, Global HIV and AIDS Programme Advisor, Concern Worldwide
Sinead Murphy, International Health Liaison Nurse, GUIDE Clinic, St. James’ Hospital
Siobán O’Brien Green, Coordinator, Migrant Women's Health Services Project, AkiDwA
Angela O’Shea, Network Development Manager, Network of Women’s Refuges and Support Services
Andrea Scharfe Nugent, Course Director, MSc Women’s Health, Royal College of Surgeons in Ireland
Rebecca Seery, Client Support Worker, Dublin AIDS Alliance
Alwiye Xuseyn, Financial Administrator, AkiDwA
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FGM
AN OVERVIEW
Female genital mutilation (FGM) is defined as
the partial or total removal of the external female
genitalia, or any practice that purposely alters or
injures the female genital organs for non-medical
reasons. The practice is internationally recognised
as a human rights violation of women and girls.
04
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THE WORLD HEALTH ORGANIZATION’S CLASSIFICATION OF FGM (2007)
NB Women may not be able to correctly self-identify the specific type of FGM that they have experienced.
WHEN IS FGM PERFORMED?
The age at which girls undergo FGM varies by community. The most common age at which FGM is
performed is between four and ten years, although this can vary from birth until pregnancy with first
child (primagravia).
WHO PERFORMS FGM?
Typically, FGM is performed by an older woman in the community who has had no medical training or by a
traditional birth attendant (TBA). The use of anaesthetics and antiseptics is uncommon. Instruments used
to perform FGM include razor blades, knives, pieces of glass, scissors and scalpels. In some instances,
several girls will be cut using the same instrument, heightening the risk of infections including HIV.
WHY IS FGM PERFORMED?
• tradition
• rite of passage into womanhood
• religion (although no religion includes FGM as a requirement)
• preservation of virginity until marriage
• social acceptance, among peers as well as for marriage
• cultural/aesthetic reasons
The origins of FGM are largely unknown, but the practice predates contemporary world religions. Local
and cultural factors are likely to be some of the reasons for the development and continuation of the
practice over time.
WHY DOES FGM CONTINUE?
The practice of FGM persists today for several reasons. In many instances, parents want their daughters to
undergo FGM in order to avoid stigmatisation or social exclusion by the rest of the community. In practising
communities, it is strongly believed that a girl is not marriageable if she has not undergone FGM.
Therefore, she may become a social outcast.
The negative health complications associated with FGM are often poorly understood within practising
communities. If the correlation between FGM and certain complications was more clearly realised among
community members, particularly maternal morbidity/mortality and fistula formation, it is
likely that FGM’s prevalence would decrease.
Partial or total removal of the clitoris and/or the prepuce (clitoridectomy).
Partial or total removal of the clitoris and the labia minora, with or without excision of the
labia majora (excision).
Narrowing of the vaginal orifice with creation of a covering seal by cutting and appositioning
the labia minora and/or the labia majora, with or without excision of the clitoris (infibulation).
All other harmful procedures to the female genitalia for non-medical purposes, e.g. pricking, piercing,
incising, scraping and cauterisation.
05
Type I
Type II
Type III
Type IV
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HEALTH CONSEQUENCES OF FGM
For detailed definitions, please refer to: FGM – GYNAECOLOGICAL AND HEALTH ISSUES
A major World Health Organization study found a significant increase in adverse obstetric outcomes
for women who had undergone FGM [1]. The study involved 28,393 women at 28 obstetric centres in
six African countries (Burkina Faso, Ghana, Kenya, Nigeria, Senegal and Sudan). Deliveries are more
likely to be complicated by Caesarean section, post-partum haemorrhage, episiotomy, an extended
stay in maternity hospital, resuscitation of the infant, and inpatient perinatal death.
WHAT LEGISLATION EXISTS AGAINST FGM?
Many nations around the world have passed specific legislation against the practice of FGM, including
16 African countries. European countries that have legislation applicable to FGM include, but are not
limited to, Austria, Belgium, Spain and the UK. In some of the African countries that have passed
anti-FGM legislation, there has been a trend toward the medicalisation of the practice instead of
an overall decrease in prevalence. Several of the industrialised nations with anti-FGM legislation
include the principle of extraterritoriality as a stipulation. That is, it is illegal to perform FGM on
a resident of such a nation, even if it is done elsewhere.
There is currently no specific legislation in Ireland criminalising FGM. However, FGM would be
considered illegal under the Criminal Justice Act of 2000 (bodily injury), as well as the Non-Fatal
Offences Against the Person Act of 1997. Although not specifically included in Children First
National Guidelines for the Protection and Welfare of Children, FGM would fall under the scope
of this document. It is important to note that legislation alone is often insufficient in having a
significant impact on the eradication and prevention of FGM. In addition to legal measures, culturally
sensitive interventions and the development of a national capacity to stop the practice are imperative
steps toward ending it. However, legislation can act as a deterrent to the continuation of the practice
and a legitimate way for parents to refute family pressure to submit their daughters to the practice.
THE SHORT-TERM COMPLICATIONS
OF FGM CAN INCLUDE:
Death
Haemorrhage
Infection and failure of the wound to heal
Injury or trauma to adjoining areas, such as the
urethra and anus
Shock from severe pain and bleeding
Surgical mishap
Tetanus
Transmission of HIV and other viruses
Decrease or loss of sexual sensation
Difficult and complicated childbirth
Dysmenorrhoea, difficulties in menstruation including
passing menses
Dyspareunia (painful intercourse)
Incontinence and difficulty urinating
Pelvic inflammatory disease (PID) and infertility
Psychological trauma
Scarring (with or without keloid formation) and hardening of the
vaginal tissue, causing constant pain around the genital area
Sebaceous cyst development
THE LONG-TERM COMPLICATIONS
OF FGM CAN INCLUDE:
06
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FGM
PREVALENCE:
GLOBAL, EUROPEAN
AND IRISH STATISTICS
The World Health Organization estimates that
between 100 and 140 million women worldwide
have undergone female genital mutilation (FGM),
and 3 million girls are at risk of FGM in Africa
annually. This equates to 6,000 women and girls
undergoing FGM daily in the world. Prevalence
often varies widely within countries, depending
on regional and tribal cultural traditions.
07
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COUNTRY
Countries with FGM
prevalence of 90%
or above.
Approximately 80%
of total population
in survey.
*
PREVALENCE OF FGM IN PRACTISING COUNTRIES [2]
PREVALENCE OF FGM IN EUROPE
As migration to Europe from FGM-practising countries becomes an increasing trend, FGM has 
become an issue in several European countries. In many cases, families and communities will attempt
to continue to practise FGM after moving to Europe as a way of upholding traditional customs. Despite
legislative efforts to stop this practice, several studies have indicated that many girls living in Europe
are still at risk for undergoing the procedure.
A 2007 study by the UK organisation FORWARD estimated that nearly 66,000 women with FGM were
residing in England and Wales in 2001 [3]. The study speculated that this number would likely increase
in the years thereafter. The study also found that nearly 21,000 girls in England and Wales aged eight
and younger were at risk of FGM, and 11,000 of this cohort were likely to have already undergone some
type of FGM.
ESTIMATED PREVALENCE OF FGM IN 
GIRLS AND WOMEN AGED 15 – 49 YEARS (%)
YEAR SOURCE
Benin
Burkina Faso
Cameroon
Central African Republic
Chad
Congo, Democratic Republic of
Djibouti
Egypt
Eritrea
Ethiopia
Gambia
Ghana
Guinea
Guinea-Bissau
Ivory Coast
Kenya
Liberia
Mali
Mauritania
Niger
Nigeria
Senegal
Sierra Leone
Somalia
Sudan, Northern (*)
Tanzania, United Republic of
Togo
Uganda
Yemen
17
77
1.4
36
45
5
93.1
97
89
80
78.3
5
99
44.5
45
32
60
92
71
5
19
28
94
97.9
90
18
5.8
0.6
23
WHO
WHO
WHO
WHO
WHO
DHSMICS
DHSMICS
WHO
WHO
WHO
DHSMICS
WHO
WHO
DHSMICS
WHO
WHO
DHSMICS
WHO
WHO
WHO
WHO
WHO
DHSMICS
DHSMICS
DHSMICS
WHO
DHSMICS
DHSMICS
WHO
2006
2006
2006
2006
2006
NOT KNOWN
2006
2006
2006
2006
2005
2006
2006
2005
2006
2006
1986
2006
2006
2006
2006
2006
2005
2005
2000
2006
2005
2006
2006
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PREVALENCE OF FGM IN IRELAND
The prevalence of FGM in Ireland was estimated by obtaining census statistics (CSO) and other relevant
population data on the number of women residing in Ireland, originally from FGM-practising countries.
These statistics were then synthesised with global prevalence data to ascertain an estimate for the
number of women residing in Ireland who have undergone FGM. 
Data has shown that migration to Ireland from FGM-practising countries is an increasing trend. It is
therefore probable that the number of women in Ireland with FGM has also increased. The following
table provides a preliminary estimate for the prevalence of FGM in Ireland as of 2006. These numbers 
are likely to be an underestimate of the realities of FGM in Ireland.
ESTIMATED PREVALENCE OF FGM IN IRELAND (ENUMERATED BY 2006 CENSUS)
09
FGM-PRACTISING COUNTRY TOTAL NUMBER OF WOMEN FROM
FGM- PRACTISING COUNTRIES AGED
15-44 AND RESIDENT IN IRELAND
GLOBAL 
PREVALENCE
ESTIMATED
NUMBER
WITH FGM
Benin
Cameroon
Central African Republic
Congo, Democratic Republic of
Egypt
Eritrea
Ethiopia
Gambia
Ghana
Guinea
Ivory Coast
Kenya
Liberia
Mali
Niger
Nigeria
Senegal
Sierra Leone
Somalia
Sudan, Northern
Tanzania, United Republic of
Togo
Uganda
Yemen
TOTAL NUMBER
TOTAL PERCENTAGE
30
290
3
42
179
18
89
34
377
37
90
356
73
8
91
6,902
12
106
343
275
89
67
100
13
9,624
5.1
4.06
1.08
2.1
173.63
16.02
71.2
26.622
18.85
36.63
40.5
113.92
43.8
7.36
4.55
1,311.38
3.36
99.64
335.797
247.5
14.22
3.886
0.6
2.99
2,585
26.89%
17
1.4
36
5
97
89
80
78.3
5
99
45
32
60
92
5
19
28
94
97.9
90
18
5.8
0.6
23
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FGM
DEFINITION, TERMS 
AND GLOSSARY
Female genital mutilation (FGM) comprises all
procedures involving partial or total removal of 
the external female genitalia, or other injury to the
female genital organs for non-medical reasons.
It is important to realise that the term ‘female 
genital mutilation’ is unlikely to be used by a 
woman to refer to her body or related health 
issues. She may use one of the following terms 
or refer to being ‘closed’, ‘cut’ or ‘circumcised’. 
The appropriate use of terms or phrases is 
vital to encouraging communication between 
the woman and a health-care professional. 
Following on is a brief selection of terms 
commonly used to refer to FGM.
10
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The medical procedure to open up the vaginal area of a woman who has undergone FGM Type III.
The use of drying agents such as herbs, powders and other substances to dry and tighten the vagina
prior to sexual intercourse; may constitute FGM Type IV.
A form of FGM Type IV that involves cutting the vagina.
Refers to trained health-care professionals performing FGM in public or private health-care facilities.
This practice has been strongly denounced by WHO, UNFPA and other international medical and
health organisations.
Refers to FGM Type III.
A re-suturing of FGM Type III after childbirth.
Signifies ‘tradition’ in Arabic and refers to a range of practices that follow the teachings of Islam;
used mainly to refer to FGM Type I. References to the term ‘Sunna’ in the Koran are often used to
justify FGM as being a religious obligation (UNFPA).
For the World Health Organization’s classification of FGM, please refer to: FGM – AN OVERVIEW
GLOSSARY
11
COUNTRY TERM (PHONETIC PRONUNCIATION) LANGUAGE SIGNIFICANCE 
Circumcision
Circumcision or cutting
Ritual
Circumcision or cutting
Circumcision (male and female)
Circumcision (male and female)
Circumcision
Circumcision
Circumcision (male and female)
Arabic
Tigrenya
Harrari
Amharic 
Swahili
Igbo
Various
Somali
Arabic
Egypt 
Eritrea 
Ethiopia 
Kenya
Nigeria
Sierra Leone
Somalia
Sudan 
Khitan
Mkhenshab 
Absum  
Megerez 
Kutairi 
Ibi ugwu 
Bondo 
Gudniin
Tahoor 
TRADITIONAL AND REGIONAL TERMS FOR FGM
A form of FGM Type IV that involves scraping the tissue around the vaginal opening.ANGURYA CUTS
DEINFIBULATION
DRY SEX
GISHIRI CUTS
MEDICALISATION
PHARAONIC
CIRCUMCISION
REINFIBULATION
SUNNA
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FGM
THE ENCOUNTER/
CONSULTATION
BE AWARE AND INFORMED
In many countries, female genital mutilation (FGM) is an accepted and expected part of local custom.
Incidence is almost 100 per cent within certain communities. Health-care professionals need to be
aware that a significant number of women who have undergone FGM now reside in Western countries. 
Women and girls may present in various settings/circumstances, e.g. GP, obstetric/gynaecological,
psychological, asylum-seeking, domestic violence and rape/sexual assault. Presentations may include:
recurrent urinary tract/pelvic infections, infertility, abscesses, vulval cysts, fistula formations, problems
in childbirth, psychological trauma, mood disorders, eating and behavioural disturbances, and sexual
dysfunction [4].
In order to correctly identify and care for these women, health-care professionals need to be familiar
with global areas of high FGM prevalence. 
ASSESS INDIVIDUAL NEEDS
Don’t assume that all women will be aware that they have been circumcised. 
They may have vivid, vague or no memories of the procedure [5]. They may have no understanding 
of the type of FGM that they have undergone, and may not be aware of any links to subsequent health
complications. Spend time explaining how and why there may be a physical problem because of the
circumcision. Explain all options available to the woman, however, bear in mind that individuals may 
not be in a position to make decisions there and then, as they may need to consult with family members.
This may slow down the process and require further consultation(s).
FGM is most commonly performed on girls aged between four and ten, but it is also carried out at
other times, including: 
• shortly after birth
• adolescence
• at time of marriage
• at time of first pregnancy.
12
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BE SENSITIVE AND NON-JUDGEMENTAL
It is important to be non-judgemental about a woman’s cultural beliefs, irrespective of one’s own culture.
Although FGM is a human rights violation, in the societies in which it is practised, it may be viewed as
a compulsory procedure. The term ‘FGM’ may make a circumcised woman feel degraded and even insulted.
All health-care professionals need to be conscious of the political and cultural sensitivities surrounding
this subject, and in particular, the term ‘FGM’ [6].
LANGUAGE AND COMMUNICATION
Women may not volunteer information.
Where appropriate, ask about circumcision as a routine part of taking patient history. Use simple language
and images to facilitate understanding. Health-care professionals should not rely on familiar verbal and
non-verbal cues to form their medical opinions. Women may find it difficult to answer questions about
thoughts and feelings, and may not openly acknowledge or complain about pain and discomfort. Alternative
methods can be used for gauging thoughts and feelings, e.g. symbols, diagrams, analogue scales and
other creative methods [5].
If appropriate to the encounter/consultation, a health-care professional should ask the woman
about FGM in simple, familiar language, in a sensitive and caring way, such as:
• Have you been cut down below?
• Have you been closed?
• Have you been circumcised?
• I understand that female circumcision is common in some African countries.
Have you been cut down there?
Do not appear surprised or shocked with the woman’s response to any of these questions.
It may be necessary to establish with the woman if she has undergone FGM through visual aids –
firstly, to determine if she had the procedure, and secondly, to determine the type of FGM that
she has undergone. A vulval examination may also be required, and should be performed by an
appropriate health-care professional.
For further assistance, please refer to: FGM – DEFINITION, TERMS AND GLOSSARY
CONSENT AND PRIVACY
All encounters should be confidential, respectful and mindful of the woman’s dignity.
In accordance with the customs of their cultures, many women may only be comfortable discussing this
issue with another woman [7]. They may have vivid traumatic memories surrounding the event. Privacy
and discretion should be strictly adhered to, and proper informed consent obtained before examination.
Keep the number of health-care professionals to a minimum during examinations. Female health-care
professionals are essential – if one is not available, a female chaperone is appropriate. Identify how to
access interpreters in your service and use them effectively. Ensure that they can translate medical
terminology. Female interpreters are, again, preferable. It is inappropriate to use family members as
interpreters or chaperones.
CHILDREN AND FGM
Health-care professionals have a responsibility to protect children from FGM.
Many women who have undergone FGM may have left their home countries to protect their own daughters
from the practice. However, some women and their families may still support FGM, and if there are any
girls in these families, health-care professionals need to be aware of child protection issues and the rights
of these children.
13
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FGM
GYNAECOLOGICAL 
AND HEALTH ISSUES
The exact incidence of morbidity and mortality
associated with female genital mutilation (FGM)
is difficult to measure. Only a small percentage 
of complications ever come to the attention of
health-care professionals. Reasons for this may 
be due to the unavailability and distance of health 
care, ignorance or fear of legal retribution. Since 
many women undergo FGM as infants, they may 
not remember any immediate adverse effects.
Complications arising during childbirth or later 
in life may not be linked by women to the ‘surgery’ 
they underwent as children, especially if the 
FGM occurred prior to menarche. FGM-related 
complications may be considered normal and
natural to women, especially among populations 
in which FGM is prevalent. Complications may 
occur with all types of FGM, but are most frequent
with FGM Type III [8].
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Lack of access to first aid and immediate hospital access in acute situations.
Amputation of the clitoris involves cutting across the clitoral artery vessel, which has a strong vascular
flow and high pressure. Haemorrhage may also occur due to sloughing of the clot over the artery,
usually because of infection. If bleeding is very severe and uncontrolled, it may lead to exsanguination.
• death
• HIV and other blood-borne viruses (BBV)
• septicaemia
• tetanus (also due to lack of tetanus toxoid injection)
• urinary tract infection
• wound infection
Fractures, dislocations or other injuries due to restraining a struggling child. Injury to adjacent
structures, such as the urethra, labia and Bartholin’s gland.
• haemorrhagic (bleeding)
• neurogenic (pain)
• septic (infection)
• acute urinary retention and labial adhesion (almost complete closure of the vaginal 
orifice), as in infibulation, nearly always occurs because of the following:
• incontinence due to urethral damage at time of procedure
• painful micturition/urophobia due to pain and burning sensation of urine on raw wound
• upper or lower urinary tract infection due to use of unsterilised equipment
SHORT-TERM COMPLICATIONS OF FGM
Due to lack of anaesthesia or pain-relieving medication at the time of FGM procedure.AGONISING PAIN
DEATH
HAEMORRHAGE
INFECTION
(due to use of
unsterilised/
shared cutting
instruments)
INJURY
SHOCK
URINARY TRACT
PROBLEMS
15
Develops on the dorsal nerve of the clitoris; can lead to genital hypersensitivity.
Women who have undergone FGM will need a thorough and sensitive medical history taken. 
A vulval examination is necessary to determine the type of FGM that a woman has undergone, 
as some contraceptive methods are not indicated. Women with FGM are at increased risk of
recurrent vaginal and pelvic infections, therefore, avoid insertable contraceptive devices. 
Women who have undergone FGM Type III will have a reduced introital opening, which may
contraindicate certain contraceptive methods. Hormonal contraceptive methods can be
recommended with careful explanation to the woman. The World Health Organization’s 
Medical Eligibility Criteria for Contraceptive Use should be used as a reference guide [9]. 
For more information, please refer to: FGM – CONTRACEPTIVE TABLE
Difficulties in menstruation, including passing menses.
LONG-TERM COMPLICATIONS OF FGM
Due to profuse bleeding at time of FGM procedure.ANAEMIA
CLITORAL
NEUROMA
CONTRACEPTION
DYSMENORRHOEA
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From damage to ducts, e.g. Bartholin’s duct.
Formation of a keloid scar because of slow and incomplete healing of the wound and infection
after procedure, leading to excessive connective tissue in scar and possible obstructed
menstrual and urinary flow. 
• anal fissure, haemorrhoids or faecal incontinence due to lack of easy access to introitus, leading 
to anal intercourse
• dyspareunia (painful intercourse)
• impaired sexual response and enjoyment
• non-consummation due to obstruction, vaginismus or painful scar tissue
• trauma on deinfibulation by partner or traditional birth attendant (TBA)
• vaginismus with or without introital scarring
• bladder, urethral or kidney stones due to urinary stasis or obstruction
• incontinence due to urethral damage or fistula formation and over-distended bladder
• recurrent upper or lower urinary tract infections
• urinary retention and over-distension of bladder, leading to neurogenic bladder
• voiding difficulties due to urethral damage, scarring or obstruction, leading to prolonged 
bladder-emptying or altered direction of flow; can be perceived as normal by the woman
Deinfibulation, reinfibulation or obstructed labour, leading to both faecal and urinary incontinence.
16
Menstrual blood accumulates over many months in the vagina and uterus due to the closure of 
the vaginal opening by scar tissue; appears as a bluish bulging membrane on vaginal examination.
• HIV and other blood-borne viruses (BBV) due to use of unsterilised/shared cutting instruments
• infertility due to tubal damage from infection
• miscarriage from recurrent infections
• recurrent pelvic and urinary tract infections
• aggravated atrophic symptoms after menopause
• neuronal trauma/damage leading to insensate vulva
• poor wound-healing due to infection, malnutrition, anaemia
• retention cysts from damage to ducts
• ulceration, skin breakdown and bleeding due to recurrent trauma
• vulval and dermoid abscesses
• chronic pelvic inflammatory disease (PID)
• dysmenorrhoea due to genital tract obstruction
• during procedures requiring speculum examination, e.g. smear-taking, insertion of intrauterine 
contraceptive devices (IUCD)
May result from blocked menstrual flow.ENDOMETRIOSIS
HAEMATOCOLPOS
INFECTION
LOCAL VULVAL 
PROBLEMS
PAIN
RETENTION CYSTS 
AND ABSCESSES
SCARRING 
(with or without
keloid formation)
SEXUAL
DIFFICULTIES
URINARY TRACT
PROBLEMS
VESICOVAGINAL 
OR RECTOVAGINAL 
FISTULA
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FGM
OBSTETRIC ISSUES
COMPLICATIONS
• Risks can be higher with more extensive female genital mutilation (FGM) [8].
• FGM Type III causes a direct mechanical barrier to delivery.
FGM Types I, II and IV can be presented with unintentional vulval and vaginal scarring and adhesion, 
narrowing and obliteration of the vaginal opening.
• Inadequate assessment may physically compromise mother and foetus. 
Prolonged or obstructed labour, difficult antenatal and intrapartum vaginal assessment, proteinuria 
during pregnancy due to contamination, catheterisation and retention of urine in labour.
• Fear of labour due to small-size introitus and tender vulval scarring.
• Delayed labour, mainly in second stage of labour.
• Episiotomies and perineal tears are the most common complication.
More perineal damage is noted with FGM. Pain may lead to arrest of labour, i.e. the woman may be 
reluctant to push in the second stage of labour. Adequate pain relief is essential.
• Infection, haemorrhage, fistula, maternal death, stillbirth and neonatal death.
MANAGEMENT OF ANTENATAL CARE
• The antenatal period is the optimum time to identify a woman who has undergone FGM. 
During this time, counselling by skilled practitioners should take place with the woman and her 
partner regarding the best management to achieve a safe delivery and prevent future FGM. 
• Counsel the woman and her partner about the consequences of FGM, propose a birth plan, and plan
possible deinfibulation (in cases of FGM Type III).
• Developing a rapport between the obstetrical team and the woman is vital.
Scheduling frequent antenatal visits allows the woman to become more familiar and open to the 
team as they make decisions regarding her care.
• Recurrent urinary tract infections (UTIs) during pregnancy are a known risk factor for preterm 
labour and sepsis.
It is important to be vigilant about screening women with FGM for recurrent urinary tract infections, 
as they are at particular risk.
• Usually, pregnant women with FGM Type III should undergo deinfibulation between 20 and 28 
weeks, allowing the area to completely heal well before delivery.
• The woman’s birth plan should address analgesia and anaesthesia in labour.
WOMEN PRESENTING LATE IN DELIVERY
Women may delay presenting to the maternity hospital for a number of reasons. An uncontrolled
delivery may lead to extensive laceration and haemorrhage. Tears may involve the urethra and bladder
anteriorly and the rectum posteriorly. If not managed correctly, there is a high risk of fistula formation 
in these cases. Fistula repair should take place in an operating theatre with adequate anaesthesia.
Appropriate surgical management should then be applied, i.e. experienced surgeons should be
consulted according to the injury.
17
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INTRAPARTUM CARE/WOMEN PRESENTING IN EARLY LABOUR
• Use a sensitive, sympathetic, non-judgemental approach with the woman.
• Develop a rapport.
• If language is a barrier, obtain a female interpreter (non-family member).
• Involve the woman’s partner, if possible.
• Explain FGM (its complications and reversibility) by drawing diagrams or anatomical models.
• Make an anterior midline incision in the early stage(s) of labour.
ANTERIOR MIDLINE INCISION (FORMERLY ANTERIOR EPISIOTOMY)
When the introitus is aberrantly closed, such as
in FGM Type III, it is difficult to assess cervical
dilation. The scar can be opened anteriorly, and
there is little bleeding from relatively avascular
scar tissue. The incision should begin at the
vaginal opening, extend anteriorly in the midline,
and not extend beyond the urethra, as it may
cause excessive bleeding due to the rich blood
supply in the clitoral region [10]. The edges of
anterior incision should be sutured after labour
(leaving the introitus open), unless suturing
beforehand will control excessive bleeding.
Do not reinfibulate.
POST-NATAL CARE
• The mother/woman with FGM does not fit into the category of a routine antenatal visit; she will
require extra time for post-natal follow-up.
• Health-care professionals should address the specific needs of women with FGM in a sensitive
and compassionate manner, with an emphasis on good post-natal hygiene.
• Under WHO guidelines and UK law, in cases of FGM Type III, no reinfibulation of the vulval area
should be performed [11].
Extensive counselling may be required for women and their partners in order to understand the
associated risks of reinfibulation, such as:
• retention of lochia and sepsis
• urinary tract infection and sepsis
• poor healing, haemorrhage and infection
• future obstetrical complications.
REMEMBER: PRIMUM NON NOCERUM, ‘FIRST DO NO HARM’
• Keep clear documentation in maternity records, for future pregnancies.
• Make onward referral(s), if necessary, to urogynaecologic physiotherapy, especially in cases of
FGM Type III.
• For child protection reasons, it is imperative to make referrals and get support from the social
work team and public health nurse, particularly in cases where a daughter is born [12].
18
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FGM
PSYCHOLOGICAL
ISSUES
Research suggests that women who have undergone
female genital mutilation (FGM) are at an increased 
risk of developing psychological and emotional health
problems [13]. 
While research in this area is limited, one UK study
describes the psychological effects of FGM on 53
women [5]. It found that women who have had FGM
Types I and II are less likely to experience the serious
adverse psychological effects of FGM, compared with
those who have had FGM Type III, which has been 
linked with post-traumatic stress disorder (PTSD).
19
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WHILE RESEARCH IN THE AREA OF THE PSYCHOLOGICAL IMPLICATIONS OF
FGM IS LIMITED, INDIVIDUAL DISORDERS HAVE BEEN IDENTIFIED AS:
• anxiety 
• depression
• low self-esteem
• fear of intimacy
• relationship problems
• emotional disturbance.
NB It is important to be aware that not all women will experience adverse psychological effects as a
result of FGM.
KEY FGM-RELATED ANXIETY TIMES [5, 12, 14]
PSYCHOSEXUAL AND RELATIONSHIP ISSUES FOLLOWING FGM
Women who have undergone FGM are more likely to experience psychosexual health problems than
non-circumcised women, which can lead to long-term marriage and relationship problems [15]. 
These problems may affect both the woman and man in a couple. 
Psychosexual health problems may include:
• lack of sexual desire 
• decreased initiation of sexual activity with partner 
• inability to reach orgasm.
The psychological implications of FGM may include: 
• feelings of indifference 
• loneliness 
• depression
• body-image concerns
• low self-esteem
• emotional problems.
Anxiety surrounding menstrual flow and pelvic pain.
Anticipation of wedding night and ensuing physical pain.
Fear of intimacy and pain related to sexual intercourse.
• Fear of pain and anxiety surrounding gynaecological and obstetric procedures and delivery.
• Fear of deinfibulation and severe tearing of vagina during childbirth.
• Fear of post-delivery reinfibulation.
MENSTRUATION
PRE-MARRIAGE
FOLLOWING 
MARRIAGE
PREGNANCY
AND CHILDBIRTH
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Post-traumatic stress disorder (PTSD) can be defined as ‘the development of characteristic symptoms
following exposure to an extreme form of traumatic stress’ [16].
Determining factors in the development of PTSD are [5]:
• typology of FGM – greater risk with FGM Type III
• absence of community support
• appraisal of the event as negative
• absence of anaesthetic
• age of the woman at time of circumcision; psychological problems are exacerbated if circumcision 
takes place in an older girl or when the girl is old enough to be fully aware of what is being done 
to her [12].
MANIFESTATION
The onset of symptoms can be immediate or may be delayed by months or years, including:
• flashbacks – having repeated intrusive memories or nightmares of the event, which could be 
triggered by obstetric/gynaecological procedures
• guilt or shame
• anxiety disorders
• depression
• unexplained physical symptoms, e.g. back pain, headaches.
TREATMENT
Basic counselling skills include being aware of the following:
• privacy and confidentiality
• patience
• creating a trusting relationship
• remaining non-judgemental
• understanding non-verbal cues from your client 
• being empathetic and appreciative of what your client is going through.
The National Institute for Health and Clinical Excellence Guidelines (UK, 2005) recommends offering
trauma-focused cognitive behavioural therapy. Appropriate referral(s) should also be encouraged [17]. 
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FGM
CONTRACEPTIVE
TABLE
+ Can use. Follow World Health Organization’s Medical Eligibility Criteria for Contraceptive Use, 
3rd edn. 2004.
- Not indicated or may be difficult to use.
NB Efficacy rates are based on correct and consistent use (with necessary training or instruction, 
where appropriate) of the chosen contraceptive method. 
Combined Oral Contraceptive Pill 
Effectiveness: 99%
Combined Contraceptive Patch (Evra) 
Effectiveness: 99%
Progesterone-Only Pill
Effectiveness: 96-99%
Intravaginal Combined Contraceptive Ring (Nuvaring)
Effectiveness: 99%
Progestogen-Only Implant (Implanon) 
Effectiveness: 99%
Progestogen-Only Injectables (Depo-Provera)
Effectiveness: 99%
Levonorgestrel-Releasing Intrauterine System (Mirena) 
Effectiveness: 99%
CONTRACEPTIVE METHOD (NON-HORMONAL)
Condoms (Male and Female)
Effectiveness: 95-99%
Spermicides
Effectiveness: 99%
Barrier Methods (Diaphragm, Cervical Cap) 
Effectiveness: 92-98%
Fertility Awareness-Based Methods
(Including Lactational Amenorrhoea Method – LAM)
Effectiveness: 80-98%
CONTRACEPTIVE METHOD (HORMONAL) FGM 
TYPE I
FGM 
TYPE II
FGM 
TYPE III
FGM 
TYPE IV
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
–
+
+
–
–
–
–
– OR +
+
+
+
–
+
+
–
+
– OR +
– OR +
+
CONTRACEPTIVE METHOD SUITABILITY IN THE PRESENCE OF FGM
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FURTHER INFORMATION
AND RESOURCES
WEBSITES
AkiDwA: African and Migrant Women’s Network in Ireland
www.akidwa.ie
FORWARD: Foundation for Women’s Health, Research and Development
www.forwarduk.org.uk
IACP: Irish Association for Counselling and Psychotherapy
www.irish-counselling.ie
IAHIP: Irish Association for Humanistic and Integrative Psychotherapy 
www.iahip.com
Irish College of General Practitioners
www.icgp.ie
ICP: Irish Council for Psychotherapy
www.psychotherapy-ireland.com
Irish Family Planning Association
www.ifpa.ie
National Institute for Health and Clinical Excellence
www.nice.org.uk
Royal College of Obstetricians and Gynaecologists
www.rcog.org.uk
Royal College of Surgeons in Ireland 
www.rcsi.ie
United Nations Population Fund
www.unfpa.org
Women’s Health Council
www.whc.ie
World Health Organization
www.who.org
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FGM Type I: Shaded areas refer to tissue removed. FGM Type II: Shaded areas refer to tissue removed.
FGM Type III FGM Type IV: Example.
FGM
TYPES OF FGM
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